insights_auto
Bakit bumaba ang 600812 6.55%?
Tingnan ang Higit pang Detalyechevron_right
600812:SHA
North China Pharmaceutical Co Ltd
CN¥5.85
arrow_downward
-6.55%(-0.41) 1D
Okt 19, 3:00:02 PM GMT+8 · CNY
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 600812...
Buksan
CN¥6.10
Mataas
CN¥6.26
Mababa
CN¥5.72
Avg. na dami
79.88M
Dami
218.44M
Dividend
0.60%
Bawat tatlong buwang dividend
CN¥0.01
Petsa ng ex-dividend
Hun 11, 2026
P/E ratio
81.54
Mataas nang 52-wk
CN¥6.90
Mababa nang 52-wk
CN¥4.11
EPS
CN¥0.07
Mga natitirang share
1.63B
Bilang ng mga empleyado
10K
Buksan
CN¥6.10
Mataas
CN¥6.26
Mababa
CN¥5.72
Avg. na dami
79.88M
Dami
218.44M
Dividend
0.60%
Bawat tatlong buwang dividend
CN¥0.01
Petsa ng ex-dividend
Hun 11, 2026
P/E ratio
81.54
Mataas nang 52-wk
CN¥6.90
Mababa nang 52-wk
CN¥4.11
EPS
CN¥0.07
Mga natitirang share
1.63B
Bilang ng mga empleyado
10K
Mga kaugnay na stock
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Benzinga
·
4 oras ang nakalipas
Stock Market: Will S&P 500 Open Up or Down Today?
Bloomberg.com
·
13 oras ang nakalipas
Stocks Rebound From Chip Rout as Earnings Await: Markets Wrap
24/7 Wall St.
·
5 araw ang nakalipas
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
MarketWatch
·
1 buwan ang nakalipas
Bloom Energy was just named to the S&P 500. These other stocks are joining the index as well.
Profile
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Tungkol sa North China Pharmaceutical Co Ltd
CEO-
Mga Empleyado9.97K
ItinatagDis 20, 1992
Headquarters-
Sektor-
Website-